EUVIMEDEUVIMED entdecken
Leitlinie

ONS Guidelines™ for Cancer Treatment–Related Lymphedema

Jane M Armer, Pamela L Ostby, Pamela K Ginex, Marcia Beck, Jie Deng, Mei R Fu, Bonnie B Lasinski, Suzy Lockwood, Ellen Poage, Joan White, Christine Maloney, Kerri A Moriarty und 2 weitere

Oncology Nursing Forum · 01.09.2020 · 47 (5) · 518-538

DOI: 10.1188/20.onf.518-538 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Oncology Nursing Forum, online erschienen am 01.09.2020. Verfasst von Jane M Armer und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Missouri-Columbia. Hauptthemen laut MEDLINE: Lymphedema, Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Lymphedema is a chronic condition that may result from cancer-related surgery. The incidence of lymphedema varies greatly; however, patients remain at risk for life and may experience decreased quality of life and functional capacity. Providing recommendations for an evidence-based guideline for care of cancer treatment-related lymphedema will help to improve outcomes for patients with this chronic condition. METHODOLOGIC APPROACH: A panel of healthcare professionals with patient representation convened to develop a national clinical practice guideline on prospective surveillance, risk reduction, and conservative treatment of lymphedema. Systematic reviews of the literature were conducted and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology approach was used to assess the evidence. FINDINGS: The panel made multiple recommendations for patients who are at risk for or experiencing lymphedema. IMPLICATIONS FOR NURSING: Early diagnosis and treatment of lymphedema may mitigate symptoms. This evidence-based guideline supports patients, clinicians, and other healthcare professionals in clinical decision making. SUPPLEMENTARY MATERIAL CAN BE FOUND AT HTTPS: //onf.ons.org/supplementary-material-ons-guidelines-cancer-treatment-related-lymphedema.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphedemaNeoplasmsHumansProspective StudiesQuality of LifeRisk Reduction Behavior

Stichwörter der Autor:innen

GRADEguideline developmentlymphedemaprospective surveillancesystematic review

Autor:innen und Institutionen

  • University of Missouri-Columbia.
  • Oncology Nursing Society.
  • University of Kansas Health System
  • University of Pennsylvania
  • Boston College.
  • Texas Christian University.

ORCID-Profile: Mark Vrabel

Zitieren

APA

Armer, J. M., Ostby, P. L., Ginex, P. K., Beck, M., Deng, J., Fu, M. R., Lasinski, B. B., Lockwood, S., Poage, E., White, J., Maloney, C., Moriarty, K. A., Vrabel, M., & Morgan, R. L. (2020). ONS Guidelines™ for Cancer Treatment–Related Lymphedema. Oncology Nursing Forum, 47(5), 518-538. https://doi.org/10.1188/20.onf.518-538

Vancouver

Armer JM, Ostby PL, Ginex PK, Beck M, Deng J, Fu MR, et al. ONS Guidelines™ for Cancer Treatment–Related Lymphedema. Oncology Nursing Forum. 2020;47(5):518-538. doi:10.1188/20.onf.518-538

BibTeX
@article{Armer2020,
  author = {Armer, Jane M and Ostby, Pamela L and Ginex, Pamela K and Beck, Marcia and Deng, Jie and Fu, Mei R and Lasinski, Bonnie B and Lockwood, Suzy and Poage, Ellen and White, Joan and Maloney, Christine and Moriarty, Kerri A and Vrabel, Mark and Morgan, Rebecca L},
  title = {ONS Guidelines™ for Cancer Treatment–Related Lymphedema},
  journal = {Oncology Nursing Forum},
  year = {2020},
  volume = {47},
  number = {5},
  pages = {518--538},
  doi = {10.1188/20.onf.518-538}
}
Kostenlos starten →